menin inhibitors for the treatment of aml: insights into the covalent-101 trial
Published 1 year ago • 176 plays • Length 1:09Download video MP4
Download video MP3
Similar videos
-
1:40
the role of menin inhibitors in the treatment of aml
-
5:17
covalent-101: investigating menin inhibition with bmf-219 for treating patients with r/r aml or all
-
2:01
the future of menin inhibitors in aml
-
1:14
promising novel agents in aml: menin inhibitors
-
7:27
menin inhibitors in aml: mechanism of action, the current key data, and predicting efficacy
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
0:59
menin inhibitors in aml: providing options for patients with npm1 mutation and kmt2a rearrangement
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
6:01
we aim to cure - biomea fusion
-
4:12
the role of venetoclax-based combinations and novel agents in aml treatment
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
1:22
the promise of menin inhibition in aml
-
1:41
the emerging role of menin inhibitors in the treatment of npm1-mutated and kmt2a-rearranged r/r aml
-
1:38
the potential of menin inhibitors in specific molecular subsets of aml & all
-
2:19
insights into the phase iia mylox-1 trial: assessing efficacy of gb2064 in myelofibrosis
-
3:22
emerging aml treatments: what is menin inhibitor therapy?
-
1:57
insights into the treatment of patients with flt3-mutated aml & the role of maintenance therapy
-
0:41
promising agents in aml: menin inhibitors & magrolimab in tp53-mutated aml
-
2:22
development of novel menin-mll inhibitors for acute leukemias
-
1:30
a phase i trial investigating a novel oral flt3 inhibitor, bmf-500, in flt3-mutant aml
-
2:34
the evolution of the aml treatment paradigm